Introduction
Neurogenic pulmonary edema (NPE) is a clinical syndrome characterized by the acute
onset of pulmonary edema following a significant central nervous system (CNS) insult.
The etiology is thought to be a surge of catecholamines that results in cardiopulmonary
dysfunction. A myriad of CNS events, including spinal cord injury, subarachnoid hemorrhage
(SAH), traumatic brain injury (TBI), intracranial hemorrhage, status epilepticus,
meningitis, and subdural hemorrhage, have been associated with this syndrome [1-5].
Although NPE was identified over 100 years ago, it is still underappreciated in the
clinical arena. Its sporadic and relatively unpredictable nature and a lack of etiologic-specific
diagnostic markers and treatment modalities may in part be responsible for its poor
recognition at the bedside. In this manuscript, we will review the anatomical origin
of NPE, outline the various possible pathophysiologic mechanisms responsible for its
development, and propose a clinical framework for the classification of NPE.
Historical background
The syndrome of NPE has been recognized for over a century. In 1903, Harvey Williams
Cushing, described the connection between CNS injury and hemodynamic dysfunction [6];
and, in 1908, W. T. Shanahan reported 11 cases of acute pulmonary edema as a complication
of epileptic seizures [7]. Francois Moutier described the sudden onset of pulmonary
edema among soldiers shot in the head in World War I [8]. Similar reports exist of
observed alveolar edema and hemorrhage in the lungs of 17 soldiers dying after isolated
bullet head wounds in the Vietnam War [1].
Epidemiology
Because much of the clinical information on NPE has been derived from case reports
and autopsy series, the true incidence of NPE is unknown and is likely underreported.
Any acute CNS insult, including spinal cord trauma, can result in pulmonary edema.
In patients with SAH, reports of NPE incidence range from 2% to 42.9% [3,9,10]. Clinically,
the likelihood of developing NPE following SAH correlates with increasing age, delay
to surgery, vertebral artery origin, and the severity of clinical and radiographic
presentation (e.g., Hunt-Hess and Fischer grades) [10,11]. Patients with SAH who develop
NPE have a higher mortality rate, nearing 10% [3]. In patients with TBI, the incidence
of NPE has been estimated to be up to 20% [12]. Rogers et al. examined a large autopsy
and inpatient database on patients with acute head injury in an effort to better characterize
NPE in this patient population. The authors found that the incidence of NPE in patients
with TBI who died at the scene was 32%. Among the TBI patients who died within 96
hours, the incidence of NPE rose to 50% [2]. There was a direct correlation between
decreasing cerebral perfusion pressure (CPP) and reduced PaO2/FiO2 ratios in the TBI
patients [2]. NPE in patients who suffer seizures is rare; however, up to 80 to 100%
of epileptics who die unexpectedly of seizures are also found to have NPE [13]. In
other series, close to one-third of patients with status epilepticus also developed
NPE [14]. Other conditions, including aqueductal glioma, multiple sclerosis, medication
overdose, arteriovenous malformations, meningitis/encephalitis and spinal cord infarction,
have been reported and linked to the formation of NPE [5,15-17].
Pathophysiology
The pathophysiology linking the neurologic, cardiac, and pulmonary conditions in NPE
has been subject to debate and controversy since the recognition of NPE as a clinical
entity. A common thread among all case descriptions of NPE is the severity and acuity
of the precipitating CNS event. Neurologic conditions that cause abrupt, rapid, and
extreme elevation in intracranial pressure (ICP) appear to be at greatest risk of
being associated with NPE [18,19]. Elevated ICP levels correlate with increased levels
of extravascular lung water (EVLW) and NPE [2,20]. The abrupt increase in ICP leading
to neuronal compression, ischemia or damage is believed to give rise to an intense
activation of the sympathetic nervous system and the release of catecholamines [2,21].
This fundamental role of catecholamines is supported by the fact that the blockade
of sympathetic activity in animal models via intrathecal lidocaine, phentolamine infusion,
or pretreatment with phenoxybenzamine mitigates the pathologic neuro-pulmonary process
[22,23] (Table 1). In addition to pharmacologic intervention, anatomical interruption
of the nervous system pathway (e.g., spinal cord transection) has also been shown
to protect against the formation of NPE (Table 1). In one animal model, NPE was prevented
by removal of one lung followed by reimplantation. This was in contrast to the pulmonary
edema that developed in the innervated intrinsic lung [24]. In a human example, NPE
has been reported in soldiers who died suddenly after gunshot wounds to the head.
The soldiers with concomitant cervical spinal cord injury (and presumably severed
neuronal connection) did not have evidence of pulmonary edema on post-mortem exam
[1]. Pulmonary edema has also been reported in patients with pheochromocytoma, presumably
from catecholamine surge [25].
Table 1
Animal studies assessing possible therapeutic interventions for neurogenic pulmonary
edema (NPE)
Intervention
Animal model
Study design/results
Alpha Blockade
Phentolamine (1 mg/kg)
Rats
Prevented pulmonary edema after induced injury to anterior hypothalamus [23]
Phenoxybenzamine (3 mg/kg)
Dogs
Prevented pulmonary artery and systemic pressure increase after CSF pressure was increased
from 100 to 200 mmHg [22]
Phenoxybenzamine (1.5 mg/kg)
Dogs
Prevented increases in pulmonary perfusion pressure and PVR and associated increases
in lung water, Qs/Qt, VD, and hypoxemia induced by ICP elevation [50]
Phentolamine (2 mg/kg)
Sheep
Prevented the expected increase in permeability and lymph flow after CNS insult [38]
Beta Blockade
Propranolol (0.5 mg/kg)
Dogs
Pulmonary artery and systemic pressure unchanged with use of beta blocker after CSF
pressure was increased from 100 to 200 mmHg [22]
Propranolol (1.5 mg/kg)
Dogs
Pretreatment with beta blocker attenuated the increase in PVR during elevation in
ICP but did not prevent increases in lung water, Qs/Qt, VD, and hypoxemia [50]
Sympathetic Outflow Denervation
Bilateral thoracic sympathectomy
Dogs & Rabbits
Sympathectomy prior to induced CNS insult did not prevent pulmonary pressure elevation
[35]
Spinal cord transection
Monkeys
NPE prevented by sympathetic denervation [18]
Cholinergic Influence
Vagotomy
Dogs & Rabbits
Vagotomy did not prevent increases in pulmonary vascular pressures [35]
Vagotomy
Monkeys
Vagotomy did not prevent NPE [18]
Other
Methylprednisone (40 mg/kg)
Rats
Prevented aconitine induced NPE and systemic HTN [51]
Hypovolemia
Rats
Lowering pulmonary blood volume by phlebotomy prevented aconitine induced NPE [51]
Naloxone
Sheep
Induced NPE could be prevented by opiate antagonism, suggesting a role for endorphins
[45]
CNS, central nervous system; CSF, cerebrospinal fluid; PVR, pulmonary vascular resistance;
Qs/Qt, pulmonary shunt; VD, dead space.
Anatomical origin of NPE
Although the exact source of sympathetic outflow has not been identified, certain
centers in the brain have been implicated. These 'NPE trigger zones' include the hypothalamus
and the medulla, specifically area A1, A5, nuclei of solitary tract and the area postrema
[5]. Area A1 is located in the ventrolateral aspect of the medulla and is composed
of catecholamine neurons which project into the hypothalamus [5]. The neurons from
area A5, located in the upper portion of the medulla, project into the preganglionic
centers for spinal cord sympathetic outflow [5]. Injury to Area A1 or disruption of
the efferent pathway between A5 and the cervical cord has been shown to result in
the formation of pulmonary edema [26]. Stimulation of area A5 also causes increases
in systemic blood pressure [27]. The nuclei of solitary tract and the area postrema
of the medulla have also been linked to the formation of NPE. These areas are related
to respiratory regulation and receive input from the carotid sinus. In animal models,
bilateral irritation of the nuclei solitary tract causes severe hypertension and NPE
[23]. Unilateral stimulation of the area postrema also results in profound hemodynamic
changes, including increased cardiac output, peripheral vascular resistance, and hypertension
[5]. Finally, NPE was shown to develop after lesions were induced in the hypothalamus
of laboratory animals [28]. In a case series of 22 patients suffering from NPE, 11
of the patients had significant radiographic abnormalities in the hypothalamus. The
presence of hypothalamic lesions among these NPE patients conferred a worse prognosis
[29].
Pathogenesis
It is the prevailing view that the autonomic response to elevated ICP plays an important
role in the pathogenesis of NPE. However, what occurs mechanistically at the level
of the pulmonary vascular endothelium remains enigmatic and theoretical. Several clinicopathologic
paradigms have been proposed to explain the clinical syndrome of NPE: 1) Neuro-cardiac;
2) Neuro-hemodynamic; 3) "blast theory"; and 4) pulmonary venule adrenergic hypersensitivity.
Neuro-cardiac NPE
Whereas NPE has traditionally been described as a 'non-cardiogenic' form of pulmonary
edema, there is evidence that, in at least a subset of patients, neurologic insult
leads to direct myocardial injury and the development of pulmonary edema. Takotsubo's
cardiomyopathy is a reversible condition characterized by depressed cardiac contractility
following a neurologically 'stressful' event. The transiently diminished lusitropy,
diastolic dysfunction, and global hypokinesis of the Takotsubo heart can render these
patients susceptible to cardiogenic pulmonary edema [30]. Connor was one of the first
investigators to describe the myocytolysis and contraction-band necrosis on myocardial
biopsies of neurosurgical patients with pulmonary edema [31]. Since this original
report, several cases of cardiac injury associated with pulmonary edema following
a CNS event have been described. In a retrospective analysis, patients with no previous
cardiac history developed acute onset of pulmonary edema in association with a SAH.
The patients all demonstrated segmental wall motion abnormalities on echocardiogram,
mildly elevated cardiac enzymes, electrocardiogram (EKG) abnormalities, and elevated
pulmonary artery occlusion pressures (PAOPs). These patients were noted to have focal
myocardial necrosis, yet had no evidence of infarction and had normal coronary arteries
[32]. Similar descriptions of reversible cardiac dysfunction have been reported among
patients with TBI and NPE [30].
As with all forms of NPE, massive sympathetic discharge following CNS insult is thought
to be the precipitating factor. More specifically, in this subset of patients with
'neuro-cardiac' NPE, it is catecholamines that induce direct myocyte injury. This
is supported by the fact that the wall motion abnormalities seen on echocardiogram
in patients with neurogenic stunned myocardium follow a pattern of sympathetic nerve
innervation [33]. Similarly, myocardial lesions have been shown in patients with pheochromocytoma,
supporting the role of catecholamine surge in the pathogenesis of stunned myocardium
[34].
Neuro-hemodynamic NPE
Unlike the direct toxic effects to the myocardium as detailed above, the 'neuro-hemodynamic'
theory posits that ventricular compliance is indirectly altered by the abrupt increases
in systemic and pulmonary pressures following CNS injury. In the original studies
by Sarnoff and Sarnoff, substantial increases in aortic and pulmonary pressures were
observed following the injection of thrombin into the intracisterna magna of dogs
and rabbits [35]. The authors noted that following the sympathetic surge, the left
ventricle had reached its workfailure threshold and failed to effectively pump against
the systemic pressures. A translocation of blood flow from the highly resistant systemic
circulation to the low resistance pulmonary circuit subsequently ensued, leading to
a hydrostatic form of pulmonary edema. The increased sizes of the left atrium and
pulmonary veins in the animals were well documented in this study, and the authors
subsequently coined the term "neuro-hemodynamic pulmonary edema" [35]. Several other
animal models have documented large elevations in left atrial, systemic and pulmonary
pressures associated with NPE [18,22,36]. One study induced graded levels of ICP in
chimpanzees. All of the animals developed systemic hypertension, but only those with
a marked increase in left atrial pressure and a decrease in cardiac output developed
pulmonary edema [18].
Blast theory
The neuro-cardiac and neuro-hemodynamic theories outlined above both suggest that
alterations in hydrostatic and Starling forces are central to the formation of pulmonary
edema following CNS injury. Although hydrostatic pressures may play a role in the
pathogenesis, this mechanism alone cannot explain the presence of red blood cells
(RBCs) and protein observed in the alveolar fluid in many NPE subjects [37,38]. The
exudative properties of the pulmonary fluid imply that alterations in vascular permeability
play a role in the pathogenesis of NPE. In order to explain the presence of both hydrostatic
factors and vascular leak, Theodore and Robin introduced the "blast theory" of NPE
[39]. Similar to the neuro-hemodynamic model, the "blast theory" posits that the severe
abrupt increases in systemic and pulmonary pressures following the catecholamine surge
result in a net shift of blood volume from the systemic circulation to the low resistance
pulmonary circulation. This increase in pulmonary venous pressure leads to the development
of transudative pulmonary edema. The "blast theory" further posits that the acute
rise in capillary pressure induces a degree of barotrauma capable of damaging the
capillary-alveolar membrane. The structural damage to the pulmonary endothelium ultimately
leads to vascular leak and persistent protein-rich pulmonary edema [39]. The pulmonary
edema according to the "blast theory" is thus the result of two mechanisms which act
synergistically: A high-pressure hydrostatic influence and pulmonary endothelial injury.
Several pre-clinical models support this mechanism [40,41]. Maron showed that barotrauma
and vascular permeability occurred when pulmonary pressures exceeded 70 torr following
CNS injury in dogs [40]. In another study, EVLW was observed when pulmonary artery
pressures reached 25 torr or greater in rabbits [41]. The authors concluded that some
degree of pulmonary hypertension is required for the development of pulmonary edema,
and that the degree of permeability is "pressure dependent" [41].
Theodore and Robin in the "blast theory" acknowledged that it is rare to document
elevated systemic and pulmonary pressures in human cases of NPE. According to their
theory, this can be explained by the fact that the sympathetic surge and subsequent
hemodynamic instability occurs at the time of the inciting event when hemodynamic
monitoring is rare [39]. During the later stages of NPE, systemic and pulmonary pressures
can return to normal, whereas the endothelial injury and vascular leak may persist
[39]. A few case reports have been able to document this sequence of events in human
subjects, lending credence to the "blast theory". One case study described a patient
who had hemodynamic monitoring at the time of a seizure that led to NPE. Within minutes
of the seizure, marked increases in systemic, pulmonary and pulmonary artery occlusion
pressures were recorded. The hemodynamics quickly normalized and two hours later,
pulmonary edema developed, which was determined to be high in protein content [37].
In another case report of a patient with an intracranial hemorrhage, extreme increases
in systemic and mean pulmonary pressures (410/200 mmHg and 48 mmHg, respectively)
lasted 4 minutes. This was followed by a dramatic decrease in the patient's oxygen
levels. The patient's pulmonary edema did not clear on radiograph for 72 hours following
the last episode of transient systemic and pulmonary hypertension. The authors concluded
that persistent vascular leak was the basis for these findings [42].
Pulmonary venule adrenergic hypersensitivity
Many reports of NPE fail to consistently demonstrate the hypertensive surges and changes
in left atrial pressures as described in the theories above. This suggests that systemic
hypertension and its effect on cardiac contractility may not always contribute to
the development of NPE. An alternative hypothesis is that the massive sympathetic
discharge following CNS injury directly affects the pulmonary vascular bed, and that
the edema develops regardless of any systemic changes. We refer to this as the 'pulmonary
venule adrenergic hypersensitivity' theory. This concept of neurally induced changes
to endothelial integrity is made plausible by the fact that pulmonary vascular beds
contain α- and β-adrenergic receptors [43]. In a well designed study by McClellan
et al. [44], CNS injury and elevated ICP was induced in dogs by cisternal saline infusion.
Autonomic activation following the CNS insult was evidenced by an increase in systemic
and pulmonary vascular pressures. The pulmonary edema developed in the dogs and was
proven to be exudative in content. When the same degree of pulmonary hypertension
and increased left atrial pressure was induced with a left atrial balloon in the control
group, pulmonary edema did not develop. The authors concluded that neurologic insult
resulted in acute lung injury (ALI), which could not be explained by hemodynamic changes,
but rather by direct neurological influences on the pulmonary endothelium [44]. In
other studies of intracranial lesions induced in sheep, pulmonary edema developed
despite normal or only mildly increased left atrial and systemic pressures [38,45].
In one of these studies, α-adrenergic blockade prevented the formation of pulmonary
edema with little systemic effect, further supporting the role of direct adrenergic
influence [38]. In human examples, continuous cardiac monitoring during the development
of NPE in patients with SAH and brain tumor resection failed to demonstrate preceding
hemodynamic changes [46-48]. These findings suggest that isolated pulmonary venoconstriction
or endothelial disruption following CNS injury may be responsible for the formation
of pulmonary edema [47,48].
Clinical characteristics
Two distinct clinical forms of NPE have been described. The early form of NPE is most
common and is characterized by the development of symptoms within minutes to hours
following neurologic injury. In contrast, the delayed form develops 12 to 24 hours
after the CNS insult [5]. The abrupt nature of respiratory distress is an impressive
feature of NPE. Typically, the patient becomes acutely dyspneic, tachypneic, and hypoxic
within minutes. Pink, frothy sputum is commonly seen and bilateral crackles and rales
are appreciated on auscultation. Sympathetic hyperactivity is common and the patient
may be febrile, tachycardic, and hypertensive, and leukocytosis may occur. Chest radiograph
will reveal bilateral hyperdense infiltrates consistent with acute respiratory distress
syndrome (ARDS) [5]. Symptoms often spontaneously resolve within 24 to 48 hours; however,
in patients with ongoing brain injury and elevated ICP, the NPE often persists.
Differential diagnosis
Because alternative conditions are common, NPE is a difficult diagnosis to establish.
The diagnosis of 'pure' NPE is a diagnosis of exclusion and, by traditional definition,
requires documentation of non-cardiogenic pulmonary edema in the setting of neurological
injury. Aggressive fluid hydration is frequently administered to neurologically injured
patients. Large volume resuscitation is especially common in SAH patients suspected
of having vasospasm, thus rendering these patients at risk for volume overload and
pulmonary edema [9]. Aspiration pneumonia is also common among CNS injured patients
and must be excluded. Aspiration pneumonia differs from NPE by the presence of clinical
clues (vomiting, gastric contents in the oropharynx, witnessed aspiration) and the
distribution of alveolar disease in dependent portions of the lungs. In contrast,
NPE is characterized by a frothy, often blood-tinged sputum and more centrally distributed
alveolar disease on radiograph [5].
Previous treatment in humans
Although numerous case reports have described the various precipitating CNS insults
and clinical scenarios associated with NPE, few studies have identified specific treatment
modalities for this condition. The management of NPE to date has largely focused on
treating the underlying neurologic condition in order to quell the sympathetic discharge
responsible for causing the lung injury. Treatment efforts to reduce ICP, including
decompression and clot evacuation, osmotic diuretics, anti-epileptics, tumor resection,
and steroids have all been associated with improvements in oxygenation [3,16,28].
Pharmacological intervention, specifically anti-α-adrenergic agents, which potentially
interrupt the vicious cycle of hemodynamic instability and subsequent respiratory
failure, has shown promise in animal models. However, there are few reports documenting
its use in humans. In one case report, a patient with TBI developed sudden onset of
bilateral infiltrates and hypoxia in the setting of elevated blood pressures, sinus
tachycardia and normal central venous pressure (CVP). This patient was successfully
treated with the α-blocking agent, chlorpromazine, as evidenced by rapid improvement
in oxygenation and hemodynamics; catecholamine levels were not measured in this report
[49].
Proposed clinical framework, diagnostic criteria, and management of NPE
NPE is an exotic form of pulmonary edema and can be considered a form of ARDS per
the consensus definition. While all cases of NPE follow a CNS event and likely originate
from sympathetic activation, downstream effects on the cardiopulmonary system vary.
Some patients may have direct myocardial injury resulting in left ventricular failure
and pulmonary edema. Others develop pulmonary edema from a non-cardiogenic mechanism
as described in the pulmonary venule hypersensitivity models. Differentiating between
'cardiogenic involvement' and 'non-cardiogenic' mechanisms is essential in the clinical
realm, as there are clear therapeutic implications. In order for this clinical entity
to be effectively studied and treated, a definition that captures a subset of patients
with NPE who may benefit from sympathetic interference would be helpful. We, therefore,
propose the following diagnostic criteria for this subset of NPE: 1) Bilateral infiltrates;
2) PaO2/FiO2 ratio < 200; 3) no evidence of left atrial hypertension; 4) presence
of CNS injury (severe enough to have caused significantly increased ICP); 5) absence
of other common causes of acute respiratory distress or ARDS (e.g., aspiration, massive
blood transfusion, sepsis). For those patients who meet the above NPE criteria, measurement
of serum catecholamines may be helpful. In those patients in whom blood pressure permits,
a trial of an α-adrenergic blocking agent, such as phentolamine, can be considered.
Conclusion
Despite decades of scientific experiments and case descriptions, the diagnosis and
management of NPE remains controversial and challenging. Although this syndrome has
been described for over a millennium, it remains underdiagnosed and underappreciated.
The exact pathophysiology of NPE is still debated and the wide variety of clinical
situations in which it occurs can obfuscate diagnosis. The sudden development of hypoxemic
respiratory failure following a catastrophic CNS event, which cannot be attributed
to other causes of ARDS, is the only universally agreed upon characteristic of NPE.
A common denominator in all cases of NPE is likely a surge in endogenous serum catecholamines
that may result in changes in cardiopulmonary hemodynamics and Starling forces. It
appears that the specific clinical manifestations of this surge may vary depending
on the individual circumstance. In some patients, cardiac dysfunction may predominate;
in others, capillary leak is the primary manifestation. These patterns have obvious
implications for the diagnosis and treatment of individual cases, including cardiac
evaluation, fluid management, and choice of inotropic or vasoactive substances such
as α-adrenergic blockade.
Abbreviations
ALI: acute lung injury; ARDS: acute respiratory distress syndrome; CNS: central nervous
system; CPP: cerebral perfusion pressure; CSF: cerebrospinal fluid; CVP: central venous
pressure; EKG: electrocardiogram; EVLW: extravascular lung water; ICP: intracranial
pressure; NPE: neurogenic pulmonary edema; PAOPs: pulmonary artery occlusion pressures;
PVR: pulmonary vascular resistance; Qs/Qt: pulmonary shunt; RBCs: red blood cells;
SAH: subarachnoid hemorrhage; TBI: traumatic brain injury; VD: dead space.
Competing interests
The authors declare that they have no competing interests.
Note
This article is one of eleven reviews selected from the Annual Update in Intensive
Care and Emergency Medicine 2012 (Springer Verlag, DOI: 10.1007/978-3-642-25716-2)
and co-published as a series in Critical Care. Other articles in the series can be
found online at http://ccforum.com/series/annualupdate2012. Further information about
the Annual Update in Intensive Care and Emergency Medicine is available from http://www.springer.com/series/8901.